https://www.marketscreener.com/quote/stock/CYNATA-THERAPEUTICS-LIMIT-14942262/news/Positive-Data-from-Cynata-MSCs-in-Second-Preclinical-Asthma-Study-24992397/?utm_source=telegram&utm_medium=social&utm_campaign=share